Takisha Pharma Private Limited - Company Profile

It is a trading private limited company based in Mumbai, Maharashtra, India, established in 2018.
2018 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Takisha Pharma Private Limited

Takisha Pharma Private Limited, a active private limited company, was established on 09 May 2018 in Mumbai, Maharashtra, India. Engaging in specialty within the trading sector, it holds CIN: U51909MH2018PTC309134. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Zameer Ul Haque Ansari (Whole-Time Director), Soofia Baby (Whole-Time Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Room No. 3, Bhim Shakti Pl Lokhande Marg, Chembur, Mumbai, Maharashtra, 400089.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909MH2018PTC309134

  • Registration Number

    309134

  • Incorporation Date

    09 May 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 10 Days
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -27.17%
  • Profit Growth **** -56.22%
  • Ebitda **** -48.10%
  • Net Worth 10.24%
  • Total Assets -2.90%
Company report

Takisha Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Takisha Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Takisha Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Zameer Ul Haque Ansari Whole-Time Director 09 May 2018 Current
Soofia Baby Whole-Time Director 09 May 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Takisha Pharma.

Takisha Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 27.17% decrease. The company also saw a substantial fall in profitability, with a 56.22% decrease in profit. The company's net worth Soared by an impressive increase of 10.24%.

Takisha Pharma revenue growth over time
Takisha Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -27.17%
*******
*******
*******
*******
Revenue from Operations
*******
 -27.17%
*******
*******
*******
*******
Total Assets
*******
 -2.90%
*******
*******
*******
*******
Profit or Loss
*******
 -56.22%
*******
*******
*******
*******
Net Worth
*******
 10.24%
*******
*******
*******
*******
EBITDA
*******
 -48.10%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Takisha Pharma?

Unlock access to Takisha Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Takisha Pharma?

Unlock and access historical data on people associated with Takisha Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Takisha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Takisha Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Takisha Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Takisha Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Takisha Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Zameer Ul Haque Ansari was appointed as a Whole-time director was appointed as a Whole-time director on 09 May 2018 & has been associated with this company since 8 years 10 days . was recorded as a recent event.

  • Director Appointment

    The activity Soofia Baby was appointed as a Whole-time director was appointed as a Whole-time director on 09 May 2018 & has been associated with this company since 8 years 10 days . was completed.

  • Company Incorporation

    The activity Takisha Pharma Private Limited was registered on 09 May 2018 with Roc Mumbai & aged 8 years 10 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Takisha Pharma Private Limited?

The CIN of Takisha Pharma Private Limited is U51909MH2018PTC309134.

Where is Takisha Pharma Private Limited headquartered?

Takisha Pharma Private Limited is headquartered at Room No. 3, Bhim Shakti Pl Lokhande Marg, Chembur, Mumbai, Maharashtra, 400089.

When was Takisha Pharma Private Limited incorporated?

Takisha Pharma Private Limited was incorporated on 09 May 2018.

Who are the current directors of Takisha Pharma Private Limited?

The current directors of Takisha Pharma Private Limited are

What is the primary industry of Takisha Pharma Private Limited?

The primary industry of Takisha Pharma Private Limited is Trading.

Is Takisha Pharma Private Limited a listed company?

Takisha Pharma Private Limited is unlisted.

What is the capital structure of Takisha Pharma Private Limited?

The authorized capital of Takisha Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available